HOME > Investors > Press Releases
2012-04-13
Approval from the Korea FDA for a Phase II clinical trial for diabetic peripheral neuropathy
2012-04-06
ViroMed’s PG201 receives market approval
2012-03-14
ViroMed Presents Results of VM202 Clinical Trials at FPN Symposium
2012-03-30
ViroMed receives approval for Phase III of VM501 by China FDA
2011-11-16
ViroMed receives approval for Phase II trial in the US for Diabetic Peripheral Neuropathy
11 12 13 14 15 16 17 18 19 20